11/05/2005 (Agence Europe) - The Commission has increased the examination deadline until 27 May for the Novaris pharmaceuticals firm's acquisition of the Hexal generic medicines, as well as a 67.7% stake in US Eon Labs Inc. In compliance with Article 10 of the Regulation (EC) 139/2004, the Commission can extend this deadline by 10 days at the request of a Member State of if companies propose commitments to make mergers compatible with the common market. Initially, the Commission was expected...